Treatment for chronic heart failure in the elderly: Current practice and problems

Heart Failure Reviews

Volumn 18, Issue 4, 2013, Pages 529-551

  Abete, Pasquale ^a   Testa, Gianluca ^a,b   Della Morte, David ^c   Gargiulo, Gaetano ^a   Galizia, Gianluigi ^d   De Santis, Domenico ^a   Magliocca, Antonio ^a   Basile, Claudia ^a   Cacciatore, Francesco ^a,d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF MOLISE   (Italy)

^c IRCCS SAN RAFFAELE PISANA   (Italy)

^d IRCCS   (Italy)

Author keywords

Adherence; Chronic heart failure; Comorbidity; Therapy

Indexed keywords

ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CAPTOPRIL; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EPLERENONE; ERYTHROMYCIN; IVABRADINE; LOSARTAN; METOLAZONE; METOPROLOL SUCCINATE; NEBIVOLOL; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PROPRANOLOL; QUINIDINE; SPIRONOLACTONE; TETRACYCLINE; TIMOLOL; UNINDEXED DRUG; VALSARTAN; VASODILATOR AGENT;

AGING; ALCOHOL ABSTINENCE; ANEMIA; ARTIFICIAL HEART PACEMAKER; BRADYCARDIA; CAREGIVER; CHRONIC DISEASE; CLINICAL PRACTICE; COGNITIVE DEFECT; COMORBIDITY; CORONARY ARTERY DISEASE; DEPRESSION; DIASTOLIC DYSFUNCTION; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG DISTRIBUTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; ELDERLY CARE; ELECTROSTIMULATION THERAPY; EVIDENCE BASED MEDICINE; FOLLOW UP; GENE THERAPY; HEALTH BEHAVIOR; HEALTH EDUCATION; HEART ASSIST DEVICE; HEART EJECTION FRACTION; HEART FAILURE; HEART STIMULATION; HUMAN; HYPERTENSION; HYPERTENSIVE CRISIS; HYPOKALEMIA; KIDNEY FAILURE; LOW DRUG DOSE; LUNG EMBOLISM; MORTALITY; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; REVIEW; SIDE EFFECT; SLEEP DISORDER; SMOKING CESSATION; SOCIAL SUPPORT; SODIUM RESTRICTION; STEM CELL TRANSPLANTATION; SYSTEMIC DISEASE; SYSTOLIC DYSFUNCTION; TACHYCARDIA; TELEMEDICINE; WEIGHT REDUCTION;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BODY MASS INDEX; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; HEART FAILURE; HUMANS; MEDICATION ADHERENCE; OBESITY; PALLIATIVE CARE; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; SELF CARE; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84879080235     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-012-9363-6     Document Type: Review

References (145)

1. Rich MW (2001) Heart failure in the 21st century: a cardiogeriatric syndrome. J Gerontol A Biol Sci Med Sci 56(2):M88-M96
2. Lloyd-Jones D, Adams RJ, Brown TM et al (2010) Heart disease and stroke statistics - 2010 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation 121(7):e1-e170. doi: 10.1161/CIRCULATIONAHA.109.192666
3. Hunt SA, Abraham WT, Chin MH et al (2009) Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation. Circulation 119:e391-e479
4. Khangura J, Goodlin SJ (2011) Heart failure treatment in the elderly. Expert Rev Cardiovasc Ther 9(9):1171-1179. doi: 10.1586/erc.11.128
5. McMurray JJ, Adamopoulos S, Anker SD et al (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European society of cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. Eur Heart J 14(8):803-869
6. Gajarsa JJ, Kloner RA (2011) Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities. Heart Fail Rev 16(1):13-21. doi: 10.1007/s10741-010- 9181-7
7. Man JP, Jugdutt BI (2012) Systolic heart failure in the elderly: optimizing medical management. Heart Fail Rev 17(4-5):563-571. doi: 10.1007/s10741-011-9282-y
8. Cacciatore F, Abete P, Mazzella F, Viati L, Della Morte D, D'Ambrosio D, Gargiulo G, Testa G, Santis D, Galizia G, Ferrara N, Rengo F (2005) Frailty predicts long-term mortality in elderly subjects with chronic heart failure. Eur J Clin Invest 35(12):723-730
9. Kinney JM (2004) Nutritional frailty, sarcopenia and falls in the elderly. Curr Opin Clin Nutr Metab Care 7(1):15-20. doi: 10.1097/00075197- 200401000-00004
10. Cheng JW, Nayar M (2009) A review of heart failure management in the elderly population. Am J Geriatr Pharmacother 7(5):233-249. doi: 10.1016/j.amjopharm.2009.10.001
11. Flather MD, Shibata MC, Coats AJ et al, SENIORS Investigators (2005) Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 26(3):215-225. doi: 10.1093/eurheartj/ehi115
12. Van Veldhuisen DJ, Cohen-Solal A, Böhm M, Anker SD, Babalis D, Roughton M, Coats AJ, Poole-Wilson PA, Flather MD, SENIORS Investigators (2009) Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: data from SENIORS (study of effects of nebivolol intervention on outcomes and rehospitalization in seniors with heart failure). J Am Coll Cardiol 53(23):2150-2158. doi: 10.1016/j.jacc.2009.02.046
13. Komajda M, Hanon O, Hochadel M, Lopez-Sendon JL, Follath F, Ponikowski P, Harjola VP, Drexler H, Dickstein K, Tavazzi L, Nieminen M (2009) Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro heart failure survey II. Eur Heart J 30(4):478-486. doi: 10.1093/eurheartj/ehn539
14. Braunstein JB, Anderson GF, Gerstenblith G, Weller W, Niefeld M, Herbert R, Wu AW (2003) Noncardiac comorbidity increases preventable hospitalizations and mortality among medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 42(7):1226-1233. doi: 10.1016/S0735-1097(03)00947-1
15. Yusuf S, Reddy S, Ounpuu S, Anand S (2001) Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104(22):2746-2753
16. Jugdutt BI (2008) Aging and remodeling during healing of the wounded heart: current therapies and novel drug targets. Curr Drug Targets 9(4):325-344. doi: 10.2174/138945008783954934
17. Cacciatore F, Gallo C, Ferrara N et al (1998) Morbidity patterns in aged population in southern Italy. A survey sampling. Arch Gerontol Geriatr 26(3):201-213. doi: 10.1016/S0167-4943(98)00003-X
18. Hogg K, Swedberg K, McMurray J (2004) Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 43(3):317-327. doi: 10.1016/j.jacc.2003.07.046
19. Fonarow GC, Stough WG, Abraham WT et al (2007) Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF registry. J Am Coll Cardiol 50(8):768-777. doi: 10.1016/j.jacc.2007.04.064
20. Ather S, Chan W, Bozkurt B, Aguilar D, Ramasubbu K, Zachariah AA, Wehrens XH, Deswal A (2012) Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol 59(11):998-1005. doi: 10.1016/j.jacc.2011.11.040
21. Ghali JK, Kadakia S, Cooper R, Ferlinz J (1988) Precipitating factors leading to decompensation of heart failure. Traits among urban blacks. Arch Intern Med 148(9):2013-2016
22. Vinson JM, Rich MW, Sperry JC, Shah AS, McNamara T (1990) Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc 38(12):1290-1295
23. Kravitz RL, Hays RD, Sherbourne CD et al (1993) Recall of recommendations and adherence to advice among patients with chronic medical conditions. Arch Intern Med 153(16):1869-1878. doi: 10.1001/archinte.153.16.1869
24. Opasich C, Febo O, Riccardi PG et al (1996) Concomitant factors of decompensation in chronic heart failure. Am J Cardiol 78(3):354-357. doi: 10.1016/S0002-9149(96)00294-9
25. Michalsen A, Konig G, Thimme W (1998) Preventable causative factors leading to hospital admission with decompensated heart failure. Heart 80(5):437-441
26. Go AS, Hylek EM, Phillips KA et al (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA 285(22):2370-2375. doi: 10.1001/archinternmed.2008.506
27. Testa G, Cacciatore F, Galizia G, Della-Morte D, Mazzella F, Russo S, Ferrara N, Rengo F, Abete P (2009) Charlson comorbidity index does not predict long-term mortality in elderly subjects with chronic heart failure. Age Ageing 38(6):734-740. doi: 10.1093/ageing/afp165
28. Jones SA (2006) Ageing to arrhythmias: conundrums of connections in the ageing heart. J Pharm Pharmacol 58(12):1571-1576. doi: 10.1211/jpp.58.12.0002
29. Rodeheffer RJ, Gerstenblith G, Becker LC, Fleg JL, Weisfeldt ML, Lakatta EG (1984) Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilatation and increased stroke volume compensate for a diminished heart rate. Circulation 69(2):203-213
30. Gandhi SK, Powers JC, Nomeir AM, Fowle K, Kitzman DW, Rankin KM, Little WC (2001) The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 344(1):17-22. doi: 10.1056/NEJM200101043440103
31. Vilela-Martin JF, Vaz-de-Melo RO, Kuniyoshi CH, Abdo AN, Yugar-Toledo JC (2011) Hypertensive crisis: clinical-epidemiological profile. Hypertens Res 34(3):367-371. doi: 10.1038/hr.2010.245
32. Maisel A, Neath SX, Landsberg J et al (2012) Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (biomarkers in acute heart failure) trial. Eur J Heart Fail 14(3):278-286. doi: 10.1093/eurjhf/hfr177
33. Musso CG, Oreopoulos DG (2011) Aging and physiological changes of the kidneys including changes in glomerular filtration rate. Nephron Physiol 119(Suppl 1):1-5. doi: 10.1159/000328010
34. Mahon NG, Blackstone EH, Francis GS et al (2002) The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure. J Am Coll Cardiol 40(6):1106-1113
35. Von Haehling S, Anker MS, Jankowska EA, Ponikowski P, Anker SD (2012) Anemia in chronic heart failure: can we treat? What to treat? Heart Fail Rev 17(2):203-210. doi: 10.1007/s10741-011-9283-x
36. Maraldi C, Volpato S, Cesari M, Onder G, Pedone C, Woodman RC, Fellin R, Pahor M, Investigators of the Gruppo Italiano di Farmacoepidemiologia nell'Anziano Study (2006) Anemia, physical disability, and survival in older patients with heart failure. J Card Fail 12(7):533-539. doi: 10.1016/j.cardfail.2006.05.002
37. Spirk D, Husmann M, Hayoz D, Baldi T, Frauchiger B, Engelberger R, Amann-Vesti B, Baumgartner I, Kucher N (2012) Predictors of in-hospital mortality in elderly patients with acute venous thrombo-embolism: the SWIss venous thromboembolism registry (SWIVTER). Eur Heart J 33(7):921-926. doi: 10.1093/eurheartj/ehr392
38. Piazza G, Goldhaber SZ (2008) Pulmonary embolism in heart failure. Circulation 118(15):1598-1601. doi: 10.1161/CIRCULATIONAHA.108.803965
39. Moser DK, Doering LV, Chung ML (2005) Vulnerabilities of patients recovering from an exacerbation of chronic heart failure. Am Heart J 150(5):984. doi: 10.1016/j.ahj.2005.07.028
40. Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353(5):487-497. doi: 10.1056/NEJMra050100
41. Testa G, Cacciatore F, Galizia G, Della-Morte D, Mazzella F, Gargiulo G, Langellotto A, Raucci C, Ferrara N, Rengo F, Abete P (2011) Depressive symptoms predict mortality in elderly subjects with chronic heart failure. Eur J Clin Invest 41(12):1310-1317. doi: 10.1111/j.1365-2362.2011.02544.x
42. Cacciatore F, Abete P, Ferrara N, Calabrese C, Napoli C, Maggi S, Varricchio M, Rengo F (1998) Congestive heart failure and cognitive impairment in an older population. Osservatorio Geriatrico Campano Study Group. J Am Geriatr Soc 46(11):1343-1348
43. Mazzella F, Cacciatore F, Galizia G, Della-Morte D, Rossetti M, Abbruzzese R, Langellotto A, Avolio D, Gargiulo G, Ferrara N, Rengo F, Abete P (2010) Social support and long-term mortality in the elderly: role of comorbidity. Arch Gerontol Geriatr 51(3):323-328. doi: 10.1016/j.archger.2010. 01.011
44. McEntee ML, Cuomo LR, Dennison CR (2009) Patient-, provider-, and system-level barriers to heart failure care. J Cardiovasc Nurs 24(4):290-298. doi: 10.1097/JCN.0b013e3181a660a0
45. Heerdink ER, Leufkens HG, Herings RM, Ottervanger JP, Stricker BH, Bakker A (1998) NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med 158(10):1108-1112. doi: 10.1001/archinte.158.10.1108
46. Rich MW (2002) Management of heart failure in the elderly. Heart Fail Rev 7(1):89-97. doi: 10.1023/A:1013706023974
47. Tsuyuki RT, McKelvie RS, Arnold JM, Avezum A Jr, Barretto AC, Carvalho AC, Isaac DL, Kitching AD, Piegas LS, Teo KK, Yusuf S (2001) Acute precipitants of congestive heart failure exacerbations. Arch Intern Med 161(9):2337-2342
48. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B, Kris-Etherton P, Harris WS, Howard B, Karanja N, Lefevre M, Rudel L, Sacks F, Van Horn L, Winston M, Wylie-Rosett J (2006) Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 114(1):82-96. doi: 10.1161/CIRCULATIONAHA.106.176158
49. Panel on Dietary Reference Intakes for Electrolytes and Water, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes; Institute of Medicine (2004) Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate, 1st edn. National Academies Press, Washington, DC
50. Carlson B, Riegel B, Moser DK (2001) Self-care abilities of patients with heart failure. Heart Lung 30(5):351-359. doi: 10.1067/mhl.2001.118611
51. Schiff GD, Fung S, Speroff T, McNutt RA (2003) Decompensated heart failure: symptoms, patterns of onset, and contributing factors. Am J Med 114(8):625-630. doi: 10.1016/S0002-9343(03)00132-3
52. Travers B, O'Loughlin C, Murphy NF, Ryder M, Conlon C, Ledwidge M, McDonald K (2007) Fluid restriction in the management of decompensated heart failure: no impact on time to clinical stability. J Card Fail 13(2):128-132. doi: 10.1016/j.cardfail.2006.10.012
53. Piano MR (2002) Alcohol and heart failure. J Card Fail 8(4):239-246. doi: 10.1054/jcaf.2002.125554
54. Cooper HA, Exner DV, Domanski MJ (2000) Light-to-moderate alcohol consumption and prognosis in patients with left ventricular systolic dysfunction. J Am Coll Cardiol 35(7):1753-1759. doi: 10.1016/S0735-1097(00) 00625-2
55. Gargiulo G, Testa G, Cacciatore F, Mazzella F, Galizia G, Della-Morte D, Langellotto A, Pirozzi G, Ferro G, Ferrara N, Rengo F, Abete P (2012) A moderate alcohol consumption predicts long-term mortality in elderly subjects with chronic heart failure. J Nutrit Health Aging (in press)
56. Jay SJ (1999) Smoking is an important component in the analysis of heart failure. Arch Intern Med 159(18):2225-2226. doi: 10.1001/archinte.159.18.2225
57. Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy C, Young JB, OPTIMIZE-HF Investigators and Coordinators (2007) Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF). Am Heart J 153(1):82.e1-82.e11. doi: 10.1016/j.ahj.2006. 10.008
58. Stead LF, Perera R, Bullen C, Mant D, Lancaster T (2008) Nicotine replacement therapy for smoking cessation [update]. Cochrane Database Syst Rev 1:CD000146
59. Aukrust P, Gullestad L, Ueland T, Damås JK, Yndestad A (2005) Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implications. Ann Med 37(2):74-85. doi: 10.1080/07853890510007232
60. Hamasha AA, Hand JS, Levy SM (1998) Medical conditions associated with missing teeth and edentulism in the institutionalized elderly. Spec Care Dentist 18(3):123-127
61. Martínez-Sellés M, García Robles JA, Muñoz R, Serrano JA, Frades E, Domínguez Muñoa M, Almendral J (2004) Pharmacological treatment in patients with heart failure: patients knowledge and occurrence of polypharmacy, alternative medicine and immunizations. Eur J Heart Fail 6(2):219-226. doi: 10.1016/j.ejheart.2003.09.009
62. Kenchaiah S, Gaziano JM, Vasan RS (2004) Impact of obesity on the risk of heart failure and survival after the onset of heart failure. Med Clin North Am 88(5):1273-1294. doi: 10.1016/j.mcna.2004.04.011
63. Anker SD, Negassa A, Coats AJ, Afzal R, Poole-Wilson PA, Cohn JN, Yusuf S (2003) Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 361(9363):1077-1083. doi: 10.1016/S0140-6736(03) 12892-9
64. Mancini DM, Walter G, Reichek N, Lenkinski R, McCully KK, Mullen JL, Wilson JR (1992) Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 85(4):1364-1373
65. Testa G, Cacciatore F, Galizia G, Della-Morte D, Mazzella F, Langellotto A, Russo S, Gargiulo G, De Santis D, Ferrara N, Rengo F, Abete P (2010) Waist circumference but not body mass index predicts long-term mortality in elderly subjects with chronic heart failure. J Am Geriatr Soc 58(8):1433-1440. doi: 10.1111/j.1532-5415.2010.02979.x
66. McDonald K (2008) Diastolic heart failure in the elderly: underlying mechanisms and clinical relevance. Int J Cardiol 125(2):197-202. doi: 10.1016/j.ijcard.2007.10.002
67. Masoudi FA, Havranek EP, Smith G et al (2003) Gender, age, and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 41(2):217-223. doi: 10.1016/S0735-1097(02)02696-7
68. Yusuf S, Pfeffer MA, Swedberg K, for the CHARM Investigators and Committees et al (2003) Effects of candesartan in patients with chronic heart failure and preserved left ventricular ejection fraction: the CHARM-preserved trial. Lancet 362(9386):777-781. doi: 10.1016/S0140-6736(03)14285-7
69. Cleland JG, Tendera M, Adamus J, for the PEP-CHF Investigators, et al (2006) The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 27(19):2338-2345. doi: 10.1093/eurheartj/ehl250
70. Massie BM, Carson PE, McMurray JJ, for the I-PRESERVE Investigators et al (2008) Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 359(23):2456-2467. doi: 10.1056/NEJMoa0805450
71. Tehrani F, Phan A, Chien CV et al (2009) Value of medical therapy in patients >80 years of age with heart failure and preserved ejection fraction. Am J Cardiol 103(6):829-833. doi: 10.1016/j.amjcard.2008.11.047
72. Faris R, Flather M, Purcell H, Henein M, Poole-Wilson P, Coats A (2002) Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials. Int J Cardiol 82(2):149-158. doi: 10.1016/S0167-5273(01)00600-3
73. Ahmed A, Rich MW, Love TE, Lloyd-Jones DM, Aban IB, Colucci WS, Adams KF, Gheorghiade M (2006) Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J 27(2):178-186. doi: 10.1093/eurheartj/ehi687
74. Neuberg GW, Miller AB, O'Connor CM, Belkin RN, Carson PE, Cropp AB, Frid DJ, Nye RG, Pressler ML, Wertheimer JH, Packer M, PRAISE Investigators (2002) Prospective randomized amlodipine survival evaluation. Diuretic resistance predicts mortality in patients with advanced heart failure. Am Heart J 144(1):31-38. doi: 10.1067/mhj.2002.123144
75. Aronow WS (2006) Treatment of systolic and diastolic heart failure in the elderly. J Am Med Dir Assoc 7:29-36
76. Garg R, Yusuf S (1995) Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative group on ACE inhibitor trials. JAMA 273(18):1450-1456
77. Lee VC, Rhew DC, Dylan M, Badamgarav E, Braunstein GD, Weingarte SR (2004) Meta-analysis: angiotensin-receptor blockers in chronic heart failure and high risk acute myocardial infarction. Ann Intern Med 141(9):693-704
78. Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ, Konstam MA, Riegger G, Klinger GH, Neaton J, Sharma D, Thiyagarajan B (2000) Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial-the Losartan heart failure survival study ELITE II. Lancet 355(9215):1582-1587
79. Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K, CHARM Investigators Committees (2003) Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-alternative trial. Lancet 362(9386):772-776. doi: 10.1016/S0140-6736(03)14284-5
80. Cohn JN, Tognoni G (2001) A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 345(23):1667-1675. doi: 10.1056/NEJMoa010713
81. McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL, Olofsson B, Yusuf S, Pfeffer MA, CHARM Investigators Committees (2003) Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-added trial. Lancet 362(9386):767-771. doi: 10.1016/S0140-6736(03)14283-3
82. Brophy JM, Joseph L, Rouleau JM (2001) Beta-blockers in congestive heart failure. A Bayesian meta-analysis. Ann Intern Med 134(7):550-560
83. Ferrara N, Davis K, Abete P, Rengo F, Harding SE (1997) Alterations in beta-adrenoceptor mechanisms in the aging heart. Relationship with heart failure. Aging 9(6):391-403
84. Kramer JM, Curtis LH, Dupree CS, Pelter D, Hernandez A, Massing M, Anstrom KJ (2008) Comparative effectiveness of beta-blockers in elderly patients with heart failure. Arch Intern Med 168(22):2422-2428. doi: 10.1001/archinternmed.2008.511
85. Go AS, Jingrong Y, Gurwitz JH, Hus J, Lane K, Platt R (2008) Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice. Arch Intern Med 168(22):2415-2421. doi: 10.1001/archinternmed.2008.506
86. Sin DD, McAlister FA (2002) The effects of b-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure. Am J Med 113:650-656
87. Cohen-Solal A, Kotecha D, van Veldhuisen DJ, Babalis D, Böhm M, Coats AJ, Roughton M, Poole-Wilson P, Tavazzi L, Flather M, SENIORS Investigators (2009) Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial. Eur J Heart Fail 11(9):872-880. doi: 10.1093/eurjhf/hfp104
88. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators. N Engl J Med 341(10):709-717. doi: 10.1056/NEJM199909023411001
89. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M, Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348(14):1309-1321. doi: 10.1056/NEJMoa030207
90. Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA (2004) Rates of hyperkalemia after publication of the randomized aldactone evaluation study. N Engl J Med 351(6):543-551. doi: 10.1056/NEJMoa040135
91. The Digitalis Investigation Group (1997) The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336(8):525-533. doi: 10.1056/NEJM199702203360801
92. Swedberg K, Komajda M, Bohm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376(9744):875-885. doi: 10.1016/S0140-6736(10)62264-7
93. Cheng JW (2006) A review of isosorbide dinitrate and hydralazine in the management of heart failure in black patients, with a focus on a new fixed dose combination. Clin Ther 28(5):666-678. doi: 10.1016/j.clinthera.2006.05.007
94. Litaker JR, Chou JY (2003) Patterns of pharmacologic treatment of congestive heart failure in elderly nursing home residents and related issues: a review of the literature. Clin Ther 25(7):1918-1935. doi: 10.1016/S0149- 2918(03)80196-0
95. Gambassi G, Forman DE, Lapane KL, Mor V, Sgadari A, Lipsitz LA, Bernabei R (2000) Management of heart failure among very old persons living in long-term care: has the voice of trials spread? The SAGE Study Group. Am Heart J 139(1 I):85-93
96. Rich MW (2010) Device therapy in the elderly heart failure patient: what is the evidence? Expert Rev Cardiovasc Ther 8(9):1203-1205. doi: 10.1586/erc.10.110
97. Dickstein K, Vardas PE, Auricchio A et al (2010) 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur Heart J 31(21):2677-2687
98. Epstein AE, DiMarco JP, Ellenbogen KA et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 51(21):e1-e62. doi: 10.1016/j.jacc.2008.02.032
99. Swindle JP, Rich MW, McCann P, Burroughs TE, Hauptman PJ (2010) Implantable cardiac device procedures in older patients: use and in-hospital outcomes. Arch Intern Med 170(7):631-637. doi: 10.1001/archinternmed.2010.30
100. Ghanbari H, Dalloul G, Hasan R et al (2009) Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Arch Intern Med 169(16):1500-1506. doi: 10.1001/archinternmed.2009.255
101. Piepoli MF, Davos C, Francis DP, Coats AJ, ExTraMATCH Collaborative (2004) Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ 328(7433):189
102. Flynn KE, Piña IL, Whellan DJ, Lin L, Blumenthal JA, Ellis SJ, Fine LJ, Howlett JG, Keteyian SJ, Kitzman DW, Kraus WE, Miller NH, Schulman KA, Spertus JA, O'Connor CM, Weinfurt KP (2009) Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 301(14):1451-1459. doi: 10.1001/jama.2009.457
103. Witham MD, Gray JM, Argo IS, Johnston DW, Struthers AD, McMurdo ME (2005) Effect of a seated exercise program to improve physical function and health status in frail patients > or = 70 years of age with heart failure. Am J Cardiol 95(9):1120-1124. doi: 10.1016/j.amjcard.2005.01.031
104. Riegel B, Carlson B (2002) Facilitators and barriers to heart failure self-care. Patient Educ Couns 46(4):287-295. doi: 10.1016/S0738-3991(01)00165-3
105. Rose EA, Gelijns AC, Moskowitz AJ et al, Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group (2001) Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345(20):1435-1443. doi: 10.1056/NEJMoa012175
106. Meyns BP, Simon A, Klotz S, Wittwer T, Schlensak C, Rega F, Burkhoff D (2011) Clinical benefits of partial circulatory support in New York Heart Association Class IIIB and early class IV patients. Eur J Cardiothorac Surg 39(5):693-698. doi: 10.1016/j.ejcts.2010.07.049
107. Ballard VL (2010) Stem cells for heart failure in the aging heart. Heart Fail Rev 15(5):447-456. doi: 10.1007/s10741-010-9160-z
108. Menasché P (2011) Stem cell therapy for chronic heart failure: lessons from a 15-year experience. C R Biol 334(7):489-496. doi: 10.1016/j.crvi.2011.03.006
109. Scheubel RJ, Zorn H, Silber RE, Kuss O, Morawietz H, Holtz J, Simm A (2003) Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 42(12):2073-2080. doi: 10.1016/j.jacc.2003.07.025
110. Strauer BE, Yousef M, Schannwell CM (2010) The acute and long-term effects of intracoronary stem cell transplantation in 191 patients with chronic heart failure: the STAR-heart study. Eur J Heart Fail 7:721-729. doi: 10.1093/eurjhf/hfq095
111. Froehlich JP, Lakatta EG, Beard E, Spurgeon HA, Weisfeldt ML, Gerstenblith G (1978) Studies of sarcoplasmic reticulum function and contraction duration in young adult and aged rat myocardium. J Mol Cell Cardiol 10(5):427-438
112. Hasenfuss G, Reinecke H, Studer R, Meyer M, Pieske B, Holtz J, Holubarsch C, Posival H, Just H, Drexler H (1994) Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2 +)-ATPase in failing and nonfailing human myocardium. Circ Res 75(3):434-442
113. Del Monte F, Hajjar RJ, Harding SE (2001) Overwhelming evidence of the beneficial effects of SERCA gene transfer in heart failure. Circ Res 88(11):E66-E67
114. Jaski BE, Jessup ML, Mancini DM, Cappola TP, Pauly DF, Greenberg B, Borow K, Dittrich H, Zsebo KM, Hajjar RJ, Calcium Up-Regulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID) Trial Investigators (2009) Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial. J Card Fail 15(3):171-181. doi: 10.1016/j.cardfail.2009.01.013
115. Lymperopoulos A, Rengo G, Koch WJ (2012) GRK2 inhibition in heart failure: something old, something new. Curr Pharm Des 18(2):186-191. doi: 10.2174/138161212799040510
116. Rengo G, Lymperopoulos A, Zincarelli C, Donniacuo M, Soltys S, Rabinowitz JE, Koch WJ (2009) Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure. Circulation 119(1):89-98. doi: 10.1161/CIRCULATIONAHA. 108.803999
117. Jaarsma T, Beattie JM, Ryder M et al, Advanced Heart Failure Study Group of the HFA of the ESC (2009) Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 11(5):433-443. doi: 10.1093/eurjhf/hfp041
118. Blinderman CD, Homel P, Billings JA, Portenoy RK, Tennstedt SL (2008) Symptom distress and quality of life in patients with advanced congestive heart failure. J Pain Symptom Manage 35(6):594-603. doi: 10.1016/j.jpainsymman.2007. 06.007
119. Johnson MJ, McDonagh TA, Harkness A, McKay SE, Dargie HJ (2002) Morphine for the relief of breathlessness in patients with chronic HF - a pilot study. Eur J Heart Fail 4(6):753-756. doi: 10.1016/S1388-9842(02)00158-7
120. Goodlin SJ, Wingate S, Pressler SJ, Teerlink JR, Storey CP (2008) Investigating pain in heart failure patients: rationale and design of the pain assessment, incidence and nature in heart failure (PAIN-HF) study. J Card Fail 14(4):276-282. doi: 10.1016/j.cardfail.2008.01.008
121. Wu JR, Moser DK, De Jong MJ, Rayens MK, Chung ML, Riegel B, Lennie TA (2009) Defining an evidence-based cutpoint for medication adherence in heart failure. Am Heart J 157(2):285-291. doi: 10.1016/j.ahj.2008.10.001
122. Vogels RL, Scheltens P, Schroeder-Tanka JM, Weinstein HC (2007) Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail 9(5):440-449. doi: 10.1016/j.ejheart.2006.11.001
123. Woo MA, Kumar R, Macey PM, Fonarow GC, Harper RM (2009) Brain injury in autonomic, emotional, and cognitive regulatory areas in patients with heart failure. J Card Fail 15(3):214-223. doi: 10.1016/j.cardfail.2008.10.020
124. Friedmann E, Thomas SA, Liu F, Morton PG, Chapa D, Gottlieb SS, Sudden Cardiac Death in Heart Failure Trial Investigators (2006) Relationship of depression, anxiety, and social isolation to chronic heart failure outpatient mortality. Am Heart J 152(5):940e1-940e8. doi: 10.1016/j.ahj.2006.05.009
125. Sherwood A, Blumenthal JA, Trivedi R, Johnson KS, O'Connor CM, Adams KF Jr, Dupree CS, Waugh RA, Bensimhon DR, Gaulden L, Christenson RH, Koch GG, Hinderliter AL (2007) Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med 167(4):367-373. doi: 10.1001/archinte.167.4.367
126. Gehi A, Haas D, Pipkin S, Whooley MA (2005) Depression and medication adherence in outpatients with coronary heart disease: findings from the heart and soul study. Arch Intern Med 165(21):2508-2513. doi: 10.1001/archinte.165.21. 2508
127. Tousoulis D, Antoniades C, Drolias A, Stefanadi E, Marinou K, Vasiliadou C, Tsioufis C, Toutouzas K, Latsios G, Stefanadis C (2008) Selective serotonin reuptake inhibitors modify the effect of beta-blockers on long-term survival of patients with end-stage heart failure and major depression. 1. J Card Fail 14(6):456-464. doi: 10.1016/j.cardfail.2008.02.015
128. Khayat RN, Jarjoura D, Patt B, Yamokoski T, Abraham WT (2009) In-hospital testing for sleep disordered breathing in hospitalized patients with decompensated heart failure-report of prevalence and patient characteristics. J Card Fail 15(9):739-746. doi: 10.1016/j.cardfail.2009.05.005
129. Cohen-Zion M, Stepnowsky C, Marler C, Shochat T, Kripke DF, Ancoli- Israel S (2001) Changes in cognitive function associated with sleep disordered breathing in older people. J Am Geriatr Soc 49(12):1622-1627. doi: 10.1046/j.1532-5415.2001.t01-1-49270.x
130. Pack AI, Dinges DF, Gehrman PR, Staley B, Pack FM, Maislin G (2006) Risk factors for excessive sleepiness in older adults. Ann Neurol 59(6):893-904. doi: 10.1002/ana.20863
131. Abete P, Bianco S, Calabrese C, Napoli C, Cacciatore F, Ferrara N, Rengo F (1997) Effects of melatonin in isolated rat papillary muscle. FEBS Lett 412(1):79-85. doi: 10.1016/S0014-5793(97)00749-7
132. Dal Corso E, Bondiani AL, Zanolla L, Vassanelli C (2007) Nurse educational activity on non-prescription therapies in patients with chronic heart failure. Eur J Cardiovasc Nurs 6(4):314-320. doi: 10.1016/j.ejcnurse.2007. 04.001
133. García Rodríguez LA, Hernández-Diaz S (2003) Nonsteroidal anti-inflammatory drugs as a trigger of clinical heart failure. Epidemiology 14(2):240-246. doi: 10.1097/00001648-200303000-00020
134. Lainscak M, Podbregar M, Kovacic D, Rozman J, von Haehling S (2011) Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial. Respir Med 105(Suppl 1):S44-S49. doi: 10.1016/S0954-6111(11)70010-5
135. Sebern M, Riegel B (2009) Contributions of supportive relationships to heart failure self-care. Eur J Cardiovasc Nurs 8(2):97-104. doi: 10.1016/j.ejcnurse.2008.07.004
136. Murray MD, Morrow DG, Weiner M, Clark DO, Tu W, Deer MM, Brater DC, Weinberger M (2004) A conceptual framework to study medication adherence in older adults. Am J Geriatr Pharmacother 2(1):36-43. doi: 10.1016/S1543-5946(04) 90005-0
137. Gazmararian JA, Baker DW, Williams MV, Parker RM, Scott TL, Green DC, Fehrenbach SN, Ren J, Koplan JP (1999) Health literacy among medicare enrollees in a managed care organization. JAMA 281(6):545-551. doi: 10.1001/jama.281.6.545
138. Sayers SL, Riegel B, Pawlowski S, Coyne JC, Samaha FF (2008) Social support and self-care of patients with heart failure. Ann Behav Med 35:70-79. doi: 10.1007/s12160-007-9003-x
139. Piette JD, Gregor MA, Share D, Heisler M, Bernstein SJ, Koelling T, Chan P (2008) Improving heart failure self-management support by actively engaging out-of-home caregivers: results of a feasibility study. Congest Heart Fail 14(1):12-18. doi: 10.1111/j.1751-7133.2008.07474.x
140. Goldberg LR, Piette JD, Walsh MN, Frank TA, Jaski BE, Smith AL, Rodriguez R, Mancini DM, Hopton LA, Orav EJ, Loh E, WHARF Investigators (2003) Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the weight monitoring in heart failure (WHARF) trial. Am Heart J 146(4):705-712. doi: 10.1016/S0002-8703(03)00393-4
141. Woodend AK, Sherrard H, Fraser M, Stuewe L, Cheung T, Struthers C (2008) Telehome monitoring in patients with cardiac disease who are at high risk of readmission. Heart Lung 37(1):36-45. doi: 10.1016/j.hrtlng.2007.04.004
142. Klersy C, De Silvestri A, Gabutti G, Raisaro A, Curti M, Regoli F, Auricchio A (2011) Economic impact of remote patient monitoring: an integrated economic model derived from a meta-analysis of randomized controlled trials in heart failure. Eur J Heart Fail 13(4):450-459. doi: 10.1093/eurjhf/hfq232
143. Lorig KR, Sobel DS, Stewart AL, Brown BW Jr, Bandura A, Ritter P, Gonzalez VM, Laurent DD, Holman HR (1999) Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial. Med Care 37(1):5-14. doi: 10.1097/00005650-199901000-00003
144. Lorenz KA, Lynn J, Dy SM, Shugarman LR, Wilkinson A, Mularski RA, Morton SC, Hughes RG, Hilton LK, Maglione M, Rhodes SL, Rolon C, Sun VC, Shekelle PG (2008) Evidence for improving palliative care at the end of life: a systematic review. Ann Intern Med 148(2):147-159
145. Afilalo J, Karunananthan S, Eisenberg MJ, Alexander KP, Bergman H (2009) Role of frailty in patients with cardiovascular disease. Am J Cardiol 103(11):1616-1621. doi: 10.1016/j.amjcard.2009.01.375